Business Description
HLB Therapeutics Co Ltd
NAICS : 541519
ISIN : KR7115450009
Compare
Compare
Traded in other countries / regions
115450.Korea IPO Date
2010-03-26Description
HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.53 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -1.04 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 14.03 | |||||
| Beneish M-Score | -2.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.7 | |||||
| 3-Year EPS without NRI Growth Rate | 14.4 | |||||
| 3-Year FCF Growth Rate | 54.6 | |||||
| 3-Year Book Growth Rate | 11.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.05 | |||||
| 9-Day RSI | 56.11 | |||||
| 14-Day RSI | 55.64 | |||||
| 6-1 Month Momentum % | 57.37 | |||||
| 12-1 Month Momentum % | 162.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | |||||
| Quick Ratio | 2.99 | |||||
| Cash Ratio | 1.71 | |||||
| Days Inventory | 46.64 | |||||
| Days Sales Outstanding | 57.02 | |||||
| Days Payable | 63.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.9 | |||||
| Shareholder Yield % | 0.81 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 14.47 | |||||
| Operating Margin % | -18.15 | |||||
| Net Margin % | -52.17 | |||||
| FCF Margin % | -20.61 | |||||
| ROE % | -18.29 | |||||
| ROA % | -13.89 | |||||
| ROIC % | -6.2 | |||||
| ROC (Joel Greenblatt) % | -185.64 | |||||
| ROCE % | -14.83 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 13.68 | |||||
| PB Ratio | 5.72 | |||||
| Price-to-Tangible-Book | 12.81 | |||||
| EV-to-EBIT | -32.1 | |||||
| EV-to-EBITDA | -46.15 | |||||
| EV-to-Revenue | 15.73 | |||||
| EV-to-FCF | -74.6 | |||||
| Price-to-Median-PS-Value | 1.22 | |||||
| Price-to-Net-Current-Asset-Value | 424.4 | |||||
| Earnings Yield (Greenblatt) % | -3.12 | |||||
| FCF Yield % | -1.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HLB Therapeutics Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 55,298.113 | ||
| EPS (TTM) (â‚©) | -381.939 | ||
| Beta | -0.58 | ||
| Volatility % | 99.15 | ||
| 14-Day RSI | 55.64 | ||
| 14-Day ATR (â‚©) | 566.24044 | ||
| 20-Day SMA (â‚©) | 10520.5 | ||
| 12-1 Month Momentum % | 162.42 | ||
| 52-Week Range (â‚©) | 3750 - 17700 | ||
| Shares Outstanding (Mil) | 79.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HLB Therapeutics Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HLB Therapeutics Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
HLB Therapeutics Co Ltd Frequently Asked Questions
What is HLB Therapeutics Co Ltd(XKRX:115450)'s stock price today?
The current price of XKRX:115450 is â‚©10750.00. The 52 week high of XKRX:115450 is â‚©17700.00 and 52 week low is â‚©3750.00.
When is next earnings date of HLB Therapeutics Co Ltd(XKRX:115450)?
The next earnings date of HLB Therapeutics Co Ltd(XKRX:115450) is .
Does HLB Therapeutics Co Ltd(XKRX:115450) pay dividends? If so, how much?
HLB Therapeutics Co Ltd(XKRX:115450) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers